查詢結果分析
相關文獻
- 大腸直腸癌病人接受表皮生長因子受體拮抗劑引起皮膚毒性的臨床評估及護理處置
- Chemotherapy and Targeted Therapy in Colorectal Cancer: The Current Status
- 標靶治療藥品之皮膚毒性預防及照護指引
- 大腸直腸癌的輔助性化學治療
- 轉移性大腸直腸癌的治療
- 大腸直腸癌之藥物治療
- 轉移性大腸直腸癌的標靶治療
- 轉移性大腸直腸癌的藥物治療策略
- 轉移性大腸直腸癌的化學治療、標靶治療與免疫療法的近期回顧
- Comparison of Efficacy of Panitumumab in Combination with Oxaliplatin-based versus Irinotecan-based Chemotherapy
頁籤選單縮合
題 名 | 大腸直腸癌病人接受表皮生長因子受體拮抗劑引起皮膚毒性的臨床評估及護理處置=Clinical Assessment and Nursing Management of Skin Toxicity in Colorectal Cancer Patients Receiving Epidermal Growth Factor Receptor Antagonist |
---|---|
作 者 | 姜亭妤; 簡淑慧; 徐鴻智; 陳淑卿; | 書刊名 | 腫瘤護理雜誌 |
卷 期 | 17:2 2017.12[民106.12] |
頁 次 | 頁5-16 |
專 輯 | 癌症病人的皮膚照護 |
分類號 | 419.77 |
關鍵詞 | 大腸直腸癌; 表皮生長因子受體拮抗劑; 皮膚毒性; 標靶治療; 皮膚照護; Colorectal cancer; Epidermal growth factor receptor antagonist; Skin toxicity; Target therapy; Skin care; |
語 文 | 中文(Chinese) |
中文摘要 | 大腸直腸癌晚期患者接受表皮生長因子受體拮抗劑會出現痤瘡性皮疹、丘疹型膿疱或皮膚乾癢等皮膚毒性,造成患者皮膚不適、身體心像改變及生活品質下降,因此,醫護人員需具備評估、照護及衛教指導能力。本文主要探討患者接受表皮生長因子受體拮抗劑引起皮膚毒性之病理機轉、導因、評估工具、醫療處置及護理照護衛教,提供患者飲食認知及日常生活照顧措施以提升生活品質。 |
英文摘要 | Advanced colorectal cancer patients received epidermal growth factor receptor antagonist therapy may cause skin toxicity, including gacneiform, papulopustular eruption, and xerosis. EGFR-skin toxicity generated skin discomfort and body image disturbance and induce poor quality of life. Healthcare providers should have assessment, nursing care, and education abilities. This article was to explore the pathology mechanism, etiology, assessment tools, medical management, nursing care education, and provide diet cognitive and daily care interventions in order to enhance quality of life. |
本系統中英文摘要資訊取自各篇刊載內容。